News|Articles|November 14, 2023

Infection Intel: AstraZeneca, DayZero and Oxford Nanopore, and More

Staying Ahead with Company Updates and Product Innovations. This week's news is from AstraZeneca, DayZero and Oxford Nanopore, Ohmnilab, and NIH.

Infection Intel is the column for Infection Control Today® (ICT®) that covers the latest news, including updates on product developments, mergers, and more from companies in the infection control and prevention field.

Newsletter

Stay prepared and protected with the Infection Control Today newsletter, delivering essential updates, best practices, and expert insights for infection prevention professionals.

Subscribe

Related Content

Several vials are being prepared for testing in a laboratory, in a studio reconstruction, in connection with a new Ebola virus in the DRC’s Ituri province, strain Bundibugyo, in the east of the country. (Adobe Stock 2028671418 by digicomphoto)

Latest CME

Video

A Shield of Protection: Unmet Needs in COVID-19 Prevention and Control

Onyema Ogbuagu, MD, FACP, FIDSA; Jeffery A. Goad, PharmD, MPH; William P. Hanage, PhD

Infection Intel: AstraZeneca, DayZero and Oxford Nanopore, and More

Related Content

Diagnostics Take Center Stage in Ebola Response as Rare Bundibugyo Outbreak Expands

Brain-Body Therapy Offers a New Approach to Mental Wellness for Infection Prevention Professionals

Infection Control Today's June's Infection Prevention and Control Crossword Puzzle

Bug of the Month: More Than a Medieval Memory

CLABSIs: A Preventable Threat Is Still Costing Hospitals and Patients